Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
NCT ID: NCT01739673
Last Updated: 2018-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2011-08-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy
NCT01106274
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
NCT01325298
Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)
NCT04731727
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
NCT01956474
Higher Irradiance in Keratoconus Ectasia
NCT01789333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultraviolet-A and riboflavin
Ultraviolet-A and riboflavin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultraviolet-A and riboflavin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ability to provide written informed consent.
3. Likely to complete all study visits.
4. Subjects must have one eye that with a diagnosis of infectious keratitis.
Exclusion Criteria
2. Descemetocele.
3. Pregnancy or breastfeeding.
4. Active Herpes corneal disease.
5. Patient is unwilling or unable to comply with a medication regimen and follow up appointments.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cxlusa
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Trattler, MD
Role: STUDY_DIRECTOR
Center For Excellence In Eye Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schwartz Laser Eye Center
Scottsdale, Arizona, United States
Davidorf Eye Group
West Hills, California, United States
Corneal Consultants of Colorado, PC
Littleton, Colorado, United States
Center for Excellence in Eye Care
Miami, Florida, United States
Minnesota Eye Consultants
Minneapolis, Minnesota, United States
Ophthalmology Associates
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
iCXL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.